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Purpose: There are several types of inﬂammatory arthritis’, with
rheumatoid arthritis (RA) as the most common. Inﬂammatory arthritic
diseases have different pathologies, but they share features, such as
joint inﬂammation and tissue destruction. It is important to treat fast
progressors aggressively in these diseases to preserve joint function.
However, presently it is not possible to identify progressors based on
standard technologies. Identiﬁcation of the patients in most need of
treatment is also important as most anti-inﬂammatory treatments are
associated with substantial side effects. Thus, limiting the patient
population in need to be treated with a certain biological agent will
improve the risk-beneﬁt ratio. We have developed and validated an
ELISA, detecting a serum protein ﬁngerprint of the helical domain of
type I collagen, speciﬁcally degraded by MMP's and destroyed by
Cathepsin K (C1M). The ELISA does not recognise other collagens, intact
collagen or other protein ﬁngerprints. The aim of the present study was
to investigate whether serological levels of C1M could identify struc-
tural progression and if C1M could be a marker of treatment efﬁcacy.
Methods: The LITHE biomarker study (n¼585) is a 1-year phase III,
double-blind, placebo (PBO)-controlled, parallel group study of Tocili-
zumab (TCZ) 4 or 8 mg/kg in RA patients on stable doses of metho-
trexate (MTX). Spearman's rank correlation was used to assess the
correlation between baseline C1M and inﬂammation (CRP), visual
analogue score pain (VAS), general health (HAQ), disease activity score
(DAS)-28-ESR and structural progression (joint space narrowing (JSN)
and modiﬁed total Sharp Score (mTSS)) at 24 and 52 weeks. Multiple
regression analysis on log-transformed data was used to assess the
effect of cofounders (CRP, age, BMI, disease duration and baseline
structural status) on baseline C1M with JSN and mTSS.
Results: At baseline, C1M was signiﬁcantly correlated to CRP
(P<0.0001), VAS pain (P<0.0001), HAQ (P<0.0001), DAS28-ESR
(P<0.0001), JSN (P¼0.0056) and mTSS (P¼0.0006). There was a corre-
lation between baseline C1M and delta-mTSS at 24 weeks (R2¼0.28,
P¼0.0084) and strongly at 52 week (R2¼0.34, p<0.0017, see table).
Baseline C1M was signiﬁcantly correlated to change in CRP at 24
(R2¼-0.31, P¼0.001) and 52 weeks (R2¼-0.36, P¼0.007). There was
a tendency for baseline C1M to be correlated with delta-JSN at week 52
(R2¼0.21, p<0.055), but not at week 24. This was conﬁrmed bymultiple
regression, in which CRP was the only confounder on effect size; beta
changed from 1.4 to 3.6 with JSN and from 3.4 to 6.0 with mTSS (Table).
The adjusted correlation coefﬁcients were 0.31 and 0.32 for delta JSN
and mTSS, respectively.
Conclusions: Serum C1M measured at baseline was correlated to
change in structural progression. In conclusion, C1M may enable
prognostic identiﬁcation of those patients who are structural pro-
gressors in inﬂammatory arthritis.Multivariate linear regression analysis. Beta, regression coefﬁcient, p-value and
n are given.
D52 weeks (JSN) D52 weeks (mTSS)
Beta P R2model n Beta P R
2
model n
LogC1M 1.4 0.0015 0.11 85 3.4 0.0001 0.17 85










3.6 <0.0001 0.31 83 6.0 <0.0001 0.32 833
THE RELATIONSHIP BETWEEN PRE-SURGICAL INTRA-ARTICULAR
INJECTION AND RISK FOR EARLY REVISION AND INFECTION
FOLLOWING TOTAL HIP ARTHROPLASTY
B. Ravi y, R. Croxford z, S. Hollands z, G.A. Hawker y. yUniv. of Toronto,
Toronto, ON, Canada; z Inst. of Clinical Evaluative Sci. (ICES), Toronto,
ON, CanadaPurpose: Intra-articular hip injections of corticosteroids or hyaluronic
acid are recommended in the management of hip osteoarthritis (OA).
While some studies have found that a subsequent total hip arthroplasty
(THA) is at risk for early revision, purportedly because of infection, these
ﬁndings are not consistent. Potential explanations for the inconsistency
of ﬁndings include variability in sample sizes, and thus power, duration
between the injection and arthroplasty, and control for potential
confounders. We sought to determine the proportion of patients who
had an intra-articular injection prior to their THA and the relationship
between pre-THA injection and risk for early revision.
Methods: We deﬁned a cohort of patients who received their ﬁrst
primary elective THA for OA between 2002-2009 utilizing health
administrative databases fromOntario, Canada. We excluded those who
had received a primary or revision arthroplasty of the hip or knee prior
to April 1, 2002, and those whose ﬁrst procedure was non-elective (e.g.
for cancer, fracture, or external cause of injury), or who had a history of
inﬂammatory arthritis. Among eligible THA recipients with OA, those
who had received1 intra-articular injection by a radiologist in the ﬁve
years prior to their THAwere identiﬁed. Those with 2+ injections in the
six months pre-THA or 3+ injections in the ﬁve years pre-THA were
excluded to avoid patients who received facet joint injections for lower
back pain. Logistic regression was used to determine the relationship
between occurrence of injection (none, 1-5 years, 6-12 months and
within 6 months of surgery) and revision within 2y of THA, after
controlling for potential confounders (income quintile, rurality, and
provider volume). A propensity score for receipt of an injection in the
6months prior to surgery was developed, and used to match these
patients to those who did not receive an injection in the 5years prior to
the THA. Rates of revision were compared between these groups to
determine the number needed to harm (NNH).
Results: Between April 1, 2002 and March 31, 2009, we identiﬁed
37,536 primary, elective THA recipients with OA. 5,907 had received an
intra-articular hip injection performed by a radiologist in the ﬁve years
preceding their surgery: 999 < 6months prior to surgery; 702 6months
to < 1y ; 783 1-5years). The mean time from intra-articular injection to
the index THA was 322d (median: 221d, IQR: 293d). Patients that had
an injection in the six months preceding surgery had increased odds for
revision within two years relative to patients who did not have an
injection (adjusted OR 2.24; 95% CI 1.44, 3.48; p¼0.0003). There was no
difference in the odds for revision for patients who received their
injection 6-12 months or 1-5years before surgery (6-12months:
adjusted OR 0.86; 95% CI 0.38, 1.94; p¼0.7156; 1-5years: adjusted OR
0.77; 95% CI 0.34, 1.74; p¼0.5135), relative to patients who did not
receive an injection pre-THA. Propensity score matching matched 986
patients with an intra-articular injection in the 6months prior to
surgery (99% of potential cases) with 2,958 patients who did not have
an injection in that time frame (8% of potential controls). After
matching, the rates of early revision in the injection and non-injection
groups were 2.23% (22/986) and 1.05% (31/2,958) (p¼0.005), respec-
tively. The number needed to harm, for THA recipients who had an
injection <6months prior to the surgery, was 84 patients.
Conclusions: Occurrence of an intra-articular injection in the 6months
prior to a primary elective THA for OA was associated with increased
risk for revision arthroplasty. Further research is needed to determine
whether this increased risk varies in relation to the solution used in the
intra-articular injection (corticosteroids versus hyaluronic acid prod-
ucts) and potential explanations for the relationship.4
T2 TEXTURE INDEX OF CARTILAGE CAN PREDICT EARLY
SYMPTOMATIC OA PROGRESSION: DATA FROM THE
OSTEOARTHRITIS INITIATIVE
K.L. Urish y, M.G. Keffalas z, J.R. Durkin x, D.J. Miller z, C.R. Chu x, T.J.
Mosher y. y Penn State Milton S. Hershey Med. Ctr., Hershey, PA, USA;
z The Pennsylvania State Univ., University Park, PA, USA; xUniv. of
Pittsburgh, Pittsburgh, PA, USA
Purpose: There is an interest in using Magnetic Resonance Imaging
(MRI) to identify pre-radiographic changes in osteoarthritis (OA) and
identify features that indicate risk for disease progression. The purpose
of this study is to identify image features derived fromMRI T2maps that
can accurately predict OA progression prior to clinically signiﬁcant
symptomatic and radiographic presentation. In normal cartilage, there is
a spatial distribution of cartilage MRI T2 values that is strongly
Abstracts / Osteoarthritis and Cartilage 21 (2013) S9–S62 S11inﬂuenced by the highly anisotropic organization of the collagenmatrix
and regional variation in cartilage water content. We hypothesize that
loss of the normal spatial distribution of cartilage MRI T2 values, as
quantiﬁed by texture features, will identify distinctive signatures of OA
prior to symptomatic or radiographic evidence of OA. This change in T2
signal homogeneity could be used to predict symptomatic disease
progression.
Methods: Patients were selected from the Osteoarthritis Initiative (OAI)
databasebasedon the change in totalWOMACscore frombaseline to three
year follow-up (79 non-OA progression and 103 OA progression patients).
The incidence cohort was used to identify a rapid progression population
of OA deﬁned as asymptomaticwith no radiographic changes at the initial
time point (WOMAC<3; KL<2) that had a large increase inWOMAC score
(greater than 10) at the three year time point. For each patient, at baseline,
725 image texture features were measured from each knee T2 map. A
linear discriminant function and feature reduction method was then
trained to quantify a texturemetric, the T2 texture index of cartilage (TIC),
based on 20 image features, to identify early OA changes on MRI.
Results: Statistically signiﬁcant differences were seen in the T2 TIC
between the OA non-progression and progression populations at the
initial baseline measurement. This image biomarker differentiates
subjects that develop OA prior to clinically signiﬁcant OA symptoms or
radiographic ﬁndings with an accuracy of 80.3% 4.3%, a sensitivity of
83.4%  5.2% and a speciﬁcity of 77.4 4.8%. These image features used
to quantify signal homogeneity through a texture metric can be
considered “image biomarkers”. These features included run length, co-
occurrence matrix, entropy, and local energy measures. When the knee
is separated into the patella, medial, and lateral compartments, in more
than 80% of knees, the texture metric that identiﬁed a knee with early
signs of OA were primarily located in only one of these compartments.
These signal changes were observed in a dominant knee compartment
that correlated with the mechanical axis of the knee.
Conclusion: We demonstrate that the T2 TIC, derived from local vari-
ation in cartilage T2 values, is able to differentiate and predict indi-
viduals that will develop symptomatic knee OA from those that remain
asymptomatic. The observation that these image features are localized
to knee compartments associated with deviation of the mechanical axis
suggests this index reﬂects early structural cartilage change related to
biomechanical properties of the knee. The ability to differentiate
patients at risk for OA progression prior to symptomatic or radiographic
presentation based on qMRI signal changeswould be valuable in clinical
and epidemiological studies for disease-modifying OA drugs (DMOADs),
joint preservation surgical interventions, and the development of post-
traumatic arthritis in ACL and meniscal injuries.
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QUALITY OF LIFE AND RADIOGRAPHIC SEVERITY OF KNEE
OSTEOARTHRITIS PREDICT TOTAL KNEE ARTHROPLASTY: DATA
FROM THE OSTEOARTHRITIS INITIATIVE
M.C. Hochberg y,z, K. Favors y,z, J.D. Sorkin y,z. yUniv. of Maryland,
Baltimore, MD, USA; zVA Maryland Hlth. Care System, Baltimore, MD, USA
Purpose: Total knee arthroplasty (TKA) is a clinically important
outcome in persons with symptomatic osteoarthritis (OA) of the knee.
Few studies, however, have examined predictors of TKA in community-
based cohorts. We analyzed data from the Osteoarthritis Initiative (OAI)
to determine the most parsimonious group of baseline variables that
robustly predicted undergoing a TKA during 5 years of follow-up.
Methods: Data for this analysis were obtained from the OAI public
access database (http://www.oai.ucsf.edu). At each annual visit through
48 months, subjects completed an extensive battery of questionnaires,
weight was measured with a balance beam scale, and ﬁxed ﬂexion,
weight-bearing PA radiographs of both knees were obtained using
a standard protocol and the Synaﬂexer platform; the 60-month
follow-up visit only involved completion of questionnaires. Subjects
reported TKAs at the time of their annual follow-up visits; these were
conﬁrmed by the Coordinating Center after review of medical records
obtained by the Clinical Centers. We examined selected variables
measured at the baseline visit for their role as predictors of TKA using
knee-speciﬁc multiple variable logistic regression models. The best
models were selected for each knee based on Chi-square values and
area under the receiver operating characteristic curve (AUC).
Results: Data from 4674 subjects enrolled in the OAI who either had
symptomatic radiographic knee OA or were at risk for this conditionwere included in this analysis. At entry, subjects had a mean (SD) age of
61.32 (9.17) years and body mass index (BMI) of 28.74 (4.82) kg/m2;
2729 (58.4%) were women and 3677 (78.75%) were white. Baseline
knee-speciﬁcWOMAC pain (0-20 scale) and function (0-68 scale) scores
were 2.56 (3.26) and 8.26 (10.63) for the right knee and 2.39 (3.43) and
8.39 (11.44) for the left knee, respectively. Baseline KOOS pain and
symptoms scores (0-100 scale) were 83.56 (17.37) and 85.95 (14.60) for
the right knee and 84.80 (18.26) and 86.49 (15.87) for the left knee,
respectively; KOOS quality of life (QoL, 0-100 scale) was 66.10 (22.43).
Distribution of Kellgren-Lawrence (KL) grades of severity of radio-
graphic knee OA at baseline was similar for both knees: 37,18, 27,14 and
4 percent had Grade 0, 1, 2, 3, 4 changes, respectively. During 60months
of follow-up, there were 91 right and 102 left TKAs. In models con-
taining clinical variables and adjusted for age, gender, BMI and race, the
best models includedWOMAC pain and KOOS QoL (AUC¼ 0.80 and 0.82
for right and left knees, respectively). When KL grade was added to
these models, the AUC improved to 0.89 and 0.90 for the right and left
knees, respectively; race, BMI and WOMAC pain were no longer
signiﬁcantly associated with TKA outcome. The best parsimonious
model included age, gender, KOOS QoL score and KL grade with an
AUC ¼ 0.89 and 0.90 for the right and left knee, respectively. Subjects
with highest odds for a TKA were those in the lowest quartile of QoL
scores and with KL grade 3 or 4 radiographic severity.
Conclusions: These data suggest that knowledge of only a patient's age,
gender, KOOSQoL score and KL grade of severity of radiographic knee OA
can predict with high accuracy the odds of undergoing a TKA over the
ensuing5years. Theseﬁndingsextendourprior report (ShurupoffK, et al:
Osteoarthritis Cart 2011;19S1:S134 [abstract #284]) that KOOS QoL and
radiographic severity can be used tomodel the outcome of "Virtual TKA".
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THE CANONICAL WNT PATHWAY IS PREDOMINANTLY ACTIVATED IN
BONE IN OSTEOARTHRITIS
T. Funck-Brentano y,z, W. Bouaziz y, V. Geoffroy y, D. Hannouche k,x, C.
Marty y, E. Hay y, M.E. Cohen-Solal y,z. y INSERM U606 - Paris Diderot
Univ., Paris, France; zDept. of Rheumatology, Lariboisière Hosp., Paris,
France; xCNRS UMR 7052 - Paris Diderot Univ., Paris, France; kDept. of
Orthopedics, Lariboisière Hosp., Paris, France
Purpose: Wnt/b-catenin pathway is a main regulator of cartilage in
osteoarthritis (OA). However, previous studies targeting this pathway in
the cartilage have brought conﬂicting results, and the kinetic of activation
of this pathway in the joint is poorly known during the development of
OA. Moreover, the activation of the pathway in the tissues surrounding
the cartilage should also be characterized as they might impact cartilage
loss. Here, we aimed to investigate Wnt activation in cartilage, bone and
synovium and the expression of Wnt antagonists over time.
Methods: Topgal mice, that express b-galactosidasewhenWnt/b-catenin
is activated, were used to assess Wnt activation in the joints in vivo. To
promote a mechanical model of OA, mice underwent joint instability by
partial meniscectomy of the medial meniscus until baseline (n¼3), 4
(n¼14), 6 (n¼13), and9 (n¼9)weeks.Dissectedkneeswere scannedusing
an ex vivo microCT, then prepared for cryosectioning to quantify varia-
tions of Wnt activity in the 3 joint tissues by X-gal staining and the
expression ofWnt antagonists such asDickkopf-relatedprotein 1 (Dkk-1),
sclerostin and secreted frizzled-related protein 3 (sFRP-3) in the cartilage
overtime.Wnt activity was assessed by the number of X-gal positive cells
per tissue volume, and was expressed as a ratio of operated to sham-
operated knees for each animal and at each time point. Non parametric
testswere used: theWilcoxon's rank test for paired variables or theMann
Withney's test for independent variables. A p value< 0.05was considered
as statistically signiﬁcant.
Results: At baseline, X-gal staining was mainly located in osteocytes of
the subchondral bone and mostly absent in the articular cartilage. Wnt
activity decreased in osteocytes at week 4 (mean expression in operated
relative to sham-operated knees 0.50  0.08, p¼0.034), and then
increased at weeks 6 and 9 (1.63  0.43, p¼0.004 and 2.33  0.82,
p¼0.009, respectively). This activity paralleled the changes of sub-
chondral bone volume. Wnt activity was found in the endocortical
surface of growing osteophytes, and in the perichondrial groove of
Ranvier. They were lowWnt activation in articular chondrocytes during
the course of OA that were however more frequently observed in focal
cartilage lesions. At week 9, Wnt activation was predominant in sub-
chondral bone, osteophytes and synovium of operated knees.
